Interleukin 9 (IL-9) is a T-cell derived factor preferentially expressed by CD4+ Th2 cells and it has been characterized both in human and murine systems. It is a pleiotropic cytokine with multiple functions on cells of the lymphoid, myeloid and mast cell lineages, as well as on lung epithelial cells. Other activities described for IL-9 support its contribution to asthma and its important role in helminthic infections, where a Th2 response can be protective and IL-9 enhances resistance or is responsible for elimination of the nematode. Nevertheless, until recently there were no studies on its role in bacterial infections in man. We have demonstrated that cytokines can modulate the specific cytotoxicity generation in peripheral blood mononuclear cells from leprosy patients and normal controls. In the present report we studied the effect of IL-9 in this experimental model. Our results indicate that IL-9 can counteract the negative effect mediated by IL-4 on the generation of M. leprae-induced cytotoxic T lymphocytes. Moreover, it can increase this lytic activity in controls and enhance the stimulatory effect of IL-2 or IL-6 in cells from leprosy patients and controls. IL-9 is also able to revert the inhibitory effect of IL-10 and IL-13 on the M. leprae-induced cytotoxic activity. Although the exact mechanism of action of IL-9 remains to be determined, interferon gamma seems to be required for the effect of IL-9 in this experimental model. These data suggest that IL-9 may have an atypical Th2 behaviour and play a role in the modulation of the immune response to mycobacterial infections.
Renauld J, Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40, 10.1016/1043-4666(90)90037-t
Macaubas, Sly, Burton, Tiller, Yabuhara, Holt, Smallacombe, Kendall, Jenmalm, Holt, Regulation of T-helper cell responses to inhalant allergen during early childhood, 10.1046/j.1365-2222.1999.00654.x
Jenmalm M. C., Van Snick J., Cormont F., Salman B., Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children, 10.1046/j.1365-2222.2001.01190.x
Turner Joseph D., Faulkner Helen, Kamgno Joseph, Cormont Frances, Van Snick Jacques, Else Kathryn J., Grencis Richard K., Behnke Jerzy M., Boussinesq Michel, Bradley Janette E., Th2 Cytokines Are Associated with Reduced Worm Burdens in a Human Intestinal Helminth Infection, 10.1086/379370
Gessner A, Immunobiol, 189, 419 (1993)
Arendse B, J Immunol, 174, 2205 (2005)
Grohmann U, J Immunol, 164, 4197 (2000)
Arras M, Am J Respir Cell Mol Biol, 24, 368 (2001)
Ridley DS, Int J Lepr Other Mycobact Dis, 34, 255 (1966)
Sasiain MC, Infect Immun, 60, 3389 (1992)
Mutis T, Eur J Immunol, 23, 2189 (1993)
de la Barrera S, Clin Exp Immunol, 99, 90 (1995)
FINK S., BARRERA S., MINNUCCI F., VALDEZ R., BALINA L. M., SASIAIN M. C., IFN-gamma, IL-6 and IL-4 Modulate M. leprae- or PPD-Specific Cytotoxic T Cells in Leprosy Patients, 10.1111/j.1365-3083.1993.tb03240.x
Aleman M., Interleukin-12 Amplifies the M. leprae hsp65-Cytotoxic Response in the Presence of Tumour Necrosis Factor-α and Interferon-γ Generating CD56+ Effector Cells: Interleukin-4 Downregulates This Effect, 10.1046/j.1365-3083.2000.00675.x
Gray Patrick W., Leung David W., Pennica Diane, Yelverton Elizabeth, Najarian Richard, Simonsen Christian C., Derynck Rik, Sherwood Pamela J., Wallace Donald M., Berger Shelby L., Levinson Arthur D., Goeddel David V., Expression of human immune interferon cDNA in E. coli and monkey cells, 10.1038/295503a0
Devos R, Nucl Acids Res, 10, 2487 (1982)
Del C. Sasiain, DE LA Barrera, Fink, Finiasz, AlemAN, FariNA, Pizzariello, Valdez, Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD, 10.1046/j.1365-2249.1998.00702.x
DE LA BARRERA S., FINIASZ M., FINK S., ILARREGUI J., ALEMAN M., OLIVARES L., FRANCO M. C., PIZZARIELLO G., DEL CARMEN SASIAIN M., NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13, 10.1111/j.1365-2249.2004.02334.x
Dugas B, Eur J Immunol, 23, 1687 (1993)
Louahed J, J Immunol, 156, 3704 (1996)
de Waal Malefyt R, Int Immunol, 7, 1405 (1995)
Devos S., Cormont F., Vrtala S., Hooghe-Peters E., Pirson F., Snick J., Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13, 10.1111/j.1365-2222.2006.02422.x
Houssiau FA, J Immunol, 150, 2634 (1993)
Renauld J-C, New insights into the role of cytokines in asthma, 10.1136/jcp.54.8.577
Fallon P. G., Smith P., Richardson E. J., Jones F. J., Faulkner H. C., Van Snick J., Renauld J.-C., Grencis R. K., Dunne D. W., Expression of Interleukin-9 Leads to Th2 Cytokine-Dominated Responses and Fatal Enteropathy in Mice with Chronic Schistosoma mansoni Infections, 10.1128/iai.68.10.6005-6011.2000
Khan W. I., Richard M., Akiho H., Blennerhasset P. A., Humphreys N. E., Grencis R. K., Van Snick J., Collins S. M., Modulation of Intestinal Muscle Contraction by Interleukin-9 (IL-9) or IL-9 Neutralization: Correlation with Worm Expulsion in Murine Nematode Infections, 10.1128/iai.71.5.2430-2438.2003
Bibliographic reference
Finiasz, M R ; Franco, M C ; de la Barrera, S ; Rutitzky, L ; Pizzariello, G ; et. al. IL-9 promotes anti-Mycobacterium leprae cytotoxicity : involvement of IFNgamma.. In: Clinical and experimental immunology, Vol. 147, no. 1, p. 139-47 (2007)